Biogen Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Cash & Equivalents	1,050	3,419	2,261	1,331	2,914	1,225	1,574	2,327	1,308	1,205	Upgrade
Short-Term Investments	0	1,474	1,541	1,279	1,562	2,313	2,115	2,569	2,121	640.5	Upgrade
Cash & Cash Equivalents	1,050	4,893	3,803	2,610	4,476	3,538	3,689	4,895	3,429	1,845	Upgrade
Cash Growth	-78.54%	28.67%	45.68%	-41.69%	26.51%	-4.09%	-24.64%	42.78%	85.79%	50.92%	Upgrade
Receivables	2,100	2,136	1,962	2,327	2,471	2,485	2,320	1,742	1,542	1,576	Upgrade
Inventory	2,527	1,344	1,352	1,069	804.2	929.9	902.7	1,002	893.4	804	Upgrade
Other Current Assets	1,182	1,418	740.8	881.1	631	687.6	962	1,093	836.9	309.8	Upgrade
Total Current Assets	6,859	9,791	7,857	6,887	8,382	7,641	7,873	8,732	6,700	4,535	Upgrade
Property, Plant & Equipment	3,730	3,703	3,792	3,845	3,674	3,601	3,182	2,502	2,188	1,766	Upgrade
Long-Term Investments	745	2,235	2,832	3,671	2,661	3,067	3,489	4,165	3,868	2,225	Upgrade
Goodwill and Intangibles	14,582	7,599	7,982	8,846	9,285	8,826	8,512	7,478	6,749	5,789	Upgrade
Other Long-Term Assets	928.6	1,226	1,415	1,370	3,232	2,154	595.9	0	0	0	Upgrade
Total Long-Term Assets	19,986	14,763	16,021	17,732	18,853	17,648	15,779	14,145	12,805	9,780	Upgrade
Total Assets	26,845	24,554	23,877	24,619	27,234	25,289	23,653	22,877	19,505	14,315	Upgrade
Accounts Payable	403.3	491.5	589.2	454.9	530.8	370.5	395.5	279.8	267.4	229.2	Upgrade
Current Debt	150	0	999.1	0	1,496	0	3.2	4.7	4.8	3.1	Upgrade
Other Current Liabilities	2,881	2,781	2,710	3,287	2,837	2,925	2,970	3,135	2,306	1,986	Upgrade
Total Current Liabilities	3,434	3,273	4,298	3,742	4,864	3,295	3,368	3,420	2,578	2,218	Upgrade
Long-Term Debt	7,188	6,614	6,604	7,828	4,872	5,937	5,935	6,513	6,522	580.3	Upgrade
Other Long-Term Liabilities	1,423	1,279	2,015	2,362	4,160	3,026	1,751	815.6	1,031	702.3	Upgrade
Total Long-Term Liabilities	8,611	7,893	8,619	10,191	9,031	8,962	7,686	7,328	7,552	1,283	Upgrade
Total Liabilities	12,045	11,166	12,918	13,933	13,895	12,257	11,055	10,748	10,130	3,501	Upgrade
Total Debt	7,338	6,614	7,604	7,828	6,368	5,937	5,938	6,517	6,526	583.4	Upgrade
Debt Growth	10.95%	-13.01%	-2.87%	22.94%	7.26%	-0.03%	-8.89%	-0.14%	1018.67%	-2.10%	Upgrade
Retained Earnings	17,628	16,467	13,912	13,976	16,455	16,257	15,810	15,072	12,208	9,284	Upgrade
Comprehensive Income	-153.7	-164.9	-106.7	-299	-135.2	-240.4	-318.4	-319.9	-224	-59.5	Upgrade
Shareholders' Equity	14,799	13,398	10,896	10,700	13,343	13,040	12,613	12,140	9,373	10,809	Upgrade
Net Cash / Debt	-6,288.3	-1,721.2	-3,801	-5,218.1	-1,891.6	-2,398.5	-2,249.2	-1,622.3	-3,097.8	1,262	Upgrade
Net Cash / Debt Growth	-	-	-	-	-	-	-	-	-	101.34%	Upgrade
Net Cash Per Share	-43.19	-11.79	-25.41	-32.35	-10.09	-11.68	-10.56	-7.41	-13.40	5.32	Upgrade
Working Capital	3,425	6,518	3,558	3,145	3,518	4,346	4,505	5,312	4,123	2,317	Upgrade
Book Value Per Share	102.28	92.21	73.08	66.50	71.32	63.64	59.33	55.59	40.63	45.72	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).